Information:
Error:
ID
34405
Description
Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00941720
Link
https://clinicaltrials.gov/show/NCT00941720
Keywords
Versions (1)
- 1/17/19 1/17/19 -
Copyright Holder
GSK group of companies
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma and Plasma Cell Neoplasm NCT00941720
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
patients with a diagnosis of plasma cell myeloma
boolean
ID.2
Item
patients with cardiac ejection fraction >= 45% or clearance by cleveland clinic faculty (ccf) cardiologist
boolean
ID.3
Item
patients with diffusion capacity of carbon monoxide (dlco) >= 45% predicted or clearance by ccf pulmonologist
boolean
ID.4
Item
patient with previously harvested peripheral blood progenitor cells with a minimum of 2 x 10^6 cd 34+ cells/kg harvested
boolean
ID.5
Item
patients receiving total body irradiation
boolean
ID.6
Item
non-myeloablative/reduced-intensity conditioning
boolean
ID.7
Item
pregnant and breast feeding patients
boolean
ID.8
Item
human immunodeficiency virus (hiv) positive
boolean
ID.9
Item
patients with serum creatinine > 2.0
boolean
ID.10
Item
prior hematopoietic stem cell (hsc) transplant
boolean